Buy or sell Zenith Epigenetics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Zenith Epigenetics Stock

Zenith Epigenetics Corp. is a research and development biotechnology company focused on new and innovative drugs by leveraging its

Founded

2013

Total Funding

$16.6M

About Zenith Epigenetics Stock

Zenith Epigenetics Corp. is a research and development biotechnology company focused on new and innovative drugs by leveraging its proprietary epigenetics platform. The company's epigenetic drug discovery platform functions by inhibiting BET bromodomains, having the potential to impact multiple diseases including autoimmune and oncology.

Funding History

March 2014$8.0M
July 2014$4.6M
May 2015$4.0M

Management

Chief Business Officer

Sanjay Lakhotia

President and CEO

Donald McCaffrey

President and Chief Executive Officer

Julie Cherrington

Chief Scientific Officer

Norman Wong

Vice President of Drug Discovery and Exploratory Development

Michael Yakes

Senior Vice President of Operations

Henrik Hansen

CFO

Brad Cann

Senior Director of Pharmacology

Ravi Jahagirdar

Chief Medical Officer

Joy Zhu

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Zenith Epigenetics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo